Patient Advocacy and Community Engagement at Alkermes

NORTHAMPTON, MA / ACCESSWIRE / December 11, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportWe have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - di...

Related Keywords

Athlone ,Westmeath ,Ireland ,United States ,Irish ,American ,America ,Jessicam Lipschitz ,Xiaoting Wu ,Research Development ,Alkermes ,Irish Cancer Society ,National Council For Mental ,Cancer Support Community ,National Comprehensive Cancer Care Network ,Clinical Trials Task ,Community Engagement ,National Alliance On Mental Illness ,Alkermes Pathways Research Awards Program Recipients ,Harvard Medical School ,Research Medical ,Mental Health America ,Clinical Research Task ,Foundation For Women Cancer Move The Message ,Cancer Foundation ,Alkermes Pathways Research ,Melanoma Research Foundation ,Icahn School Of Medicine At Mount Sinai ,Funding In Support Of Research ,Patient Assistance Programs ,Copay Savings Programs ,Co Pay Savings ,Alkermes Early Access Policy ,Early Access ,National Alliance ,Mental Illness ,National Council ,Mental Wellbeing ,Prevent Cancer Foundation ,Alkermes Inspiration Grants ,Native American ,Building Bridges ,Alkermes Pathways Research Awards ,Medical Grants ,Annual Alkermes Pathways Research Awards Program ,Icahn School ,Mount Sinai ,Pieta House ,